Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1

Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1

A correction to this paper has been published: https://doi.org/10.1007/s00280-021-04275-5

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer chemotherapy and pharmacology 2021-09, Vol.88 (3), p.563-563
Hauptverfasser: Yu, Shuo, Li, Yang, Ren, Hui, Zhou, Hong, Ning, Qian, Chen, Xue, Hu, Tinghua, Yang, Lan
Format: Artikel
Sprache:eng
Schlagworte:
Cancer Research
Correction
Medicine
Medicine & Public Health
Oncology
Pharmacology/Toxicology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 563
container_issue 3
container_start_page 563
container_title Cancer chemotherapy and pharmacology
container_volume 88
creator Yu, Shuo
Li, Yang
Ren, Hui
Zhou, Hong
Ning, Qian
Chen, Xue
Hu, Tinghua
Yang, Lan
description A correction to this paper has been published: https://doi.org/10.1007/s00280-021-04275-5
doi_str_mv 10.1007/s00280-021-04275-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2513245513</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2555483815</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2155-12dee004293b46ad169d1d747f5e5ae0044a39330451165414a07adaeb1f9dff3</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS0EokvhC3BAlrhwCXj8Z5PlVm0LVFSiEnC2Zu3JylViL3aC1Gs_OQ5bQOLQiy3P_N4bjx5jL0G8BSHad0UI2YlGSGiElq1pzCO2Aq1kIzqtHrOVUFo3phX6hD0r5UYIoUGpp-xEqc6sjZIrdrdNOZObQop8Su_59flnzQ85jWmiwqd5TDnsKVIJhWP03IVyGHAKkeelNmF0xOtrmOOeo6eYHGYXYhqR_wzIp4yxuBwOywQcqmo_L_o6LvX84vrsKzxnT3ocCr24v0_Z9w8X37afmqsvHy-3Z1eNk2BMA9IT1Q3kRu30Gj2sNx58q9vekMGlo1FtlBLaAKyNBo2iRY-0g37j-16dsjdH37rej5nKZMdQHA0DRkpzsdKAktrUs6Kv_0Nv0pzr_xfKGN2pDkyl5JFyOZWSqbeHHEbMtxaEXRKyx4RsTcj-Tsguolf31vNuJP9X8ieSCqgjUGor7in_m_2A7S-Zv5xA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2555483815</pqid></control><display><type>article</type><title>Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1</title><source>SpringerNature Journals</source><creator>Yu, Shuo ; Li, Yang ; Ren, Hui ; Zhou, Hong ; Ning, Qian ; Chen, Xue ; Hu, Tinghua ; Yang, Lan</creator><creatorcontrib>Yu, Shuo ; Li, Yang ; Ren, Hui ; Zhou, Hong ; Ning, Qian ; Chen, Xue ; Hu, Tinghua ; Yang, Lan</creatorcontrib><description>A correction to this paper has been published: https://doi.org/10.1007/s00280-021-04275-5</description><identifier>ISSN: 0344-5704</identifier><identifier>EISSN: 1432-0843</identifier><identifier>DOI: 10.1007/s00280-021-04275-5</identifier><identifier>PMID: 33856532</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Cancer Research ; Correction ; Medicine ; Medicine &amp; Public Health ; Oncology ; Pharmacology/Toxicology</subject><ispartof>Cancer chemotherapy and pharmacology, 2021-09, Vol.88 (3), p.563-563</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-8506-6302</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00280-021-04275-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00280-021-04275-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33856532$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Shuo</creatorcontrib><creatorcontrib>Li, Yang</creatorcontrib><creatorcontrib>Ren, Hui</creatorcontrib><creatorcontrib>Zhou, Hong</creatorcontrib><creatorcontrib>Ning, Qian</creatorcontrib><creatorcontrib>Chen, Xue</creatorcontrib><creatorcontrib>Hu, Tinghua</creatorcontrib><creatorcontrib>Yang, Lan</creatorcontrib><title>Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1</title><title>Cancer chemotherapy and pharmacology</title><addtitle>Cancer Chemother Pharmacol</addtitle><addtitle>Cancer Chemother Pharmacol</addtitle><description>A correction to this paper has been published: https://doi.org/10.1007/s00280-021-04275-5</description><subject>Cancer Research</subject><subject>Correction</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Pharmacology/Toxicology</subject><issn>0344-5704</issn><issn>1432-0843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kU9v1DAQxS0EokvhC3BAlrhwCXj8Z5PlVm0LVFSiEnC2Zu3JylViL3aC1Gs_OQ5bQOLQiy3P_N4bjx5jL0G8BSHad0UI2YlGSGiElq1pzCO2Aq1kIzqtHrOVUFo3phX6hD0r5UYIoUGpp-xEqc6sjZIrdrdNOZObQop8Su_59flnzQ85jWmiwqd5TDnsKVIJhWP03IVyGHAKkeelNmF0xOtrmOOeo6eYHGYXYhqR_wzIp4yxuBwOywQcqmo_L_o6LvX84vrsKzxnT3ocCr24v0_Z9w8X37afmqsvHy-3Z1eNk2BMA9IT1Q3kRu30Gj2sNx58q9vekMGlo1FtlBLaAKyNBo2iRY-0g37j-16dsjdH37rej5nKZMdQHA0DRkpzsdKAktrUs6Kv_0Nv0pzr_xfKGN2pDkyl5JFyOZWSqbeHHEbMtxaEXRKyx4RsTcj-Tsguolf31vNuJP9X8ieSCqgjUGor7in_m_2A7S-Zv5xA</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Yu, Shuo</creator><creator>Li, Yang</creator><creator>Ren, Hui</creator><creator>Zhou, Hong</creator><creator>Ning, Qian</creator><creator>Chen, Xue</creator><creator>Hu, Tinghua</creator><creator>Yang, Lan</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8506-6302</orcidid></search><sort><creationdate>20210901</creationdate><title>Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1</title><author>Yu, Shuo ; Li, Yang ; Ren, Hui ; Zhou, Hong ; Ning, Qian ; Chen, Xue ; Hu, Tinghua ; Yang, Lan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2155-12dee004293b46ad169d1d747f5e5ae0044a39330451165414a07adaeb1f9dff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cancer Research</topic><topic>Correction</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Pharmacology/Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Shuo</creatorcontrib><creatorcontrib>Li, Yang</creatorcontrib><creatorcontrib>Ren, Hui</creatorcontrib><creatorcontrib>Zhou, Hong</creatorcontrib><creatorcontrib>Ning, Qian</creatorcontrib><creatorcontrib>Chen, Xue</creatorcontrib><creatorcontrib>Hu, Tinghua</creatorcontrib><creatorcontrib>Yang, Lan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer chemotherapy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Shuo</au><au>Li, Yang</au><au>Ren, Hui</au><au>Zhou, Hong</au><au>Ning, Qian</au><au>Chen, Xue</au><au>Hu, Tinghua</au><au>Yang, Lan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1</atitle><jtitle>Cancer chemotherapy and pharmacology</jtitle><stitle>Cancer Chemother Pharmacol</stitle><addtitle>Cancer Chemother Pharmacol</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>88</volume><issue>3</issue><spage>563</spage><epage>563</epage><pages>563-563</pages><issn>0344-5704</issn><eissn>1432-0843</eissn><abstract>A correction to this paper has been published: https://doi.org/10.1007/s00280-021-04275-5</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33856532</pmid><doi>10.1007/s00280-021-04275-5</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-8506-6302</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0344-5704
ispartof Cancer chemotherapy and pharmacology, 2021-09, Vol.88 (3), p.563-563
issn 0344-5704
1432-0843
language eng
recordid cdi_proquest_miscellaneous_2513245513
source SpringerNature Journals
subjects Cancer Research
Correction
Medicine
Medicine & Public Health
Oncology
Pharmacology/Toxicology
title Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T15%3A35%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction%20to:%20PDK4%20promotes%20tumorigenesis%20and%20cisplatin%20resistance%20in%20lung%20adenocarcinoma%20via%20transcriptional%20regulation%20of%20EPAS1&rft.jtitle=Cancer%20chemotherapy%20and%20pharmacology&rft.au=Yu,%20Shuo&rft.date=2021-09-01&rft.volume=88&rft.issue=3&rft.spage=563&rft.epage=563&rft.pages=563-563&rft.issn=0344-5704&rft.eissn=1432-0843&rft_id=info:doi/10.1007/s00280-021-04275-5&rft_dat=%3Cproquest_cross%3E2555483815%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2555483815&rft_id=info:pmid/33856532&rfr_iscdi=true